Rick Hansen Institute
🇨🇦Canada
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2019-12-26
- Lead Sponsor
- Rick Hansen Institute
- Target Recruit Count
- 55
- Registration Number
- NCT02298660
- Locations
- 🇨🇦
International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia, Canada
Minocycline in Acute Spinal Cord Injury (MASC)
Phase 3
- Conditions
- Spinal Cord Injuries
- Interventions
- Drug: PlaceboProcedure: Surgical spinal cord decompressionProcedure: Maintenance of minimum mean arterial pressure (MAP)
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2014-10-30
- Lead Sponsor
- Rick Hansen Institute
- Target Recruit Count
- 248
- Registration Number
- NCT01828203
- Locations
- 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia
🇨🇦Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦University of Alberta & Royal Alexandra Hospitals, Edmonton, Alberta, Canada
News
No news found